RoundTable completes sale of topical pharmaceutical business to Mylan N.V.

RoundTable Healthcare Partners completed the sale of the topical pharmaceutical business of Renaissance Acquisition Holdings, LLC to Mylan N.V. for $950 million in cash, plus additional contingency payments of up to $50 million. RoundTable formed Renaissance in 2010 from the acquisition of two drug manufacturing and development companies, Confab Laboratories and DPT Laboratories.

DealsNorth AmericaUSBriefs